At a glance
- Originator Abbott Laboratories
- Developer Abbott Laboratories; Takeda; TAP Pharmaceutical Products
- Class Antineoplastics
- Mechanism of Action Gonadotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Female infertility; Male infertility; Prostate cancer